Innovotech Company Description

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays.

It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services.

The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food.

Innovotech Inc. is headquartered in Edmonton, Canada.

Innovotech Inc.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
Employees	16
CEO	Craig Milne

Contact Details

Address: 2011-94 Street Edmonton, Alberta T6N 1H1 Canada
Phone	780-448-0585
Website	innovotech.ca

Stock Details

Ticker Symbol	IOT
Exchange	TSX Venture Exchange
Share Class	Class A Shares
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA45772U1049
SIC Code	7310

Key Executives

Name	Position
Dr. Craig Milne B.Sc., M.B.A., Ph.D.	President, Chief Executive Officer and Director
Dr. James Timourian Ph.D.	Chairman and Secretary
Bernard Grobbelaar C.A., CPA, CA, CPA	Chief Financial Officer
Dr. Tyler Boone Ph.D.	Chief Operating Officer
Dr. Patricia Nadworny P.Eng., Ph.D.	Chief Scientific Officer and Quality and Safety Director
Dr. Merle Olson	Scientific Consultant